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The biochemical effects of administration of embelin a benzoquinone derivative from Embelia ribes and 
curcumin (diferuloyl methane) isolated from Curcuma longa against a 2 step hepatocarcinogenic 
regimen comprising of N-nitrosodiethylamine (DENA)/phenobarbital (PB) was studied in wistar strain 
male albino rats with respect to lipid profile, renal function tests and levels of blood glucose. Rats 
administered DENA/PB showed hyper cholesterolaemia, hyper triglyceridaemia, elevated low-density 
lipoproteins (LDL), free fatty acids (FFA), very-low-density lipoproteins (VLDL) levels and decreased 
urea levels. Pre- and co-treatment with embelin and curcumin for 14 weeks significantly prevented the 
biochemical alterations induced by DENA/PB. Results of our study suggest the protective and 
hypolipidemic effects of embelin and curcumin during chemically- induced hepatocarcinogenesis in 
wistar rats. 
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INTRODUCTION 
 
Cancer is the major cause of death in the developed, 
developing and underdeveloped world next only to car-
diovascular disease and hence is a major cause of mor-
bidity and mortality worldwide. Despite recent advances 
in our understanding of the biological processes leading 
to the development of cancer, there is still a need for new 
and effective agents to keep this disease under control 
(Ravelo et al., 2004). In the recent times focus on plant 
research has increased all over the world and a large 
body of evidence has collected to show immense poten-
tial of medicinal plants used in various traditional systems 
(Modzelewska et al., 2005). One of the oldest, most 
effective strategies for developing new chemotherapeu-
tics is the isolation and evaluation of chemicals of natural 
origin. The importance of natural products for drug 
discovery has been impressive.  
Embelin (2, 5 dihydroxy 3-undecyl 1, 4, benzoquinone) 
is a benzoquinone derivative from Embelia ribes Burm. 
(Family:  Myrsinaceae).  Embelin   is   reported  to  be  an  
 
 
 
*Corresponding author. E-mail: jagabiotech@gmail.com. 
effective analgesic (Atal et al., 1984; Zutshi et al., 1990) 
antifertility agent (Gupta et al., 1989; Agarwal et al., 
1986) and is reported to possess significant antiprolife-
rative effects against methylcholanthrene-induced fibro-
sarcoma in rats (Chitra et al., 1994; Chitra et al., 1995). 
Curcumin (diferuloyl methane) the active principle of Cur-
cuma longa (Family: Zingiberaceae) is documented with 
several medicinal properties. It is a well known anti 
cancer agent and is found to induce apoptosis by a p 53 
dependent pathway and by activating caspase 3 and 8 
(Chan et al., 2000). It is a potent antioxidant (Rukkumani 
et al., 2003) and anti-inflammatory agent (Handler et al., 
2007). Recent studies from our laboratory have confirm-
ed the chemopreventive effects of embelin and curcumin 
against N-nitrosodiethylamine (DENA)/ phenobarbital 
(PB)-induced hepatocarcinogenesis in rats (Sreepriya 
and Bali, 2005).  
N-nitrosodiethylamine is a powerful hepatocarcinogen 
that has been used as an initiating agent in some 2 stage 
(initiation and promotion) protocols for hepatocarcino-
genic studies. It is metabolized to reactive electrophilic 
reactants that alter the structure of DNA and forms alkyl 
DNA adducts (Yoshiji et al., 1991). 
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Table 1. Levels of blood glucose, blood urea and serum creatinine in the 
normal and experimental groups of rats. 
 
Group Urea Creatinine Glucose 
1 31.49 ± 4.26 1.21± 0.09 73.68 ± 5.01 
2 24.92 ± 2.34* 1.2 ± 0.09 NS 94.73 ± 6.67*** 
3 34.87 ± 5.46NS 1.2 ± 0.08 NS 75.32 ± 6.74NS 
4 30.98 ± 4.29NS 1.2 ± 0.1 NS 72.89 ± 5.36NS 
5 28.21 ± 2.38* 1.16 ± 0.12NS 73.68 ± 5.68*** 
6 30.85 ± 4.46* 1.18 ± 0.09NS 80.47 ± 6.21** 
 
Units: mg/ml. 
Values are expressed as mean ± SD. (For 6 animals in each group).  
Students`t’ test - Comparisons are made between group 2, group 3, group 4 
Vs group1; group 5, group 6 Vs group 2. 
*** P < 0.001; ** P < 0.01; * P < 0.05; NS - non significant. 
 
 
 
It induces chromosomal aberrations, micronuclei and 
sister chromatid exchanges in rat liver (Park et al., 2001). 
Phenobarbital is an antiepileptic drug that promotes 
hepa-tocarcinogenesis in rodents when administered 
subsequent to an initiating carcinogen like N-nitrosodi-
ethylamine. Over expression of glutamine synthetase is 
associated with the beta-catenin mutations in mouse liver 
tumors during promotion of hepatocarcinogenesis by 
phenobarbital (Loeppen et al., 2002). The present study 
was aimed to study the biochemical effects of curcumin 
and embelin to combat against a 2-step hepatocarcino-
genesis induced by DENA (initiator) and PB (promoter) in 
wistar rats. 
 
 
MATERIALS AND METHODS 
 
Chemicals  
 
Curcumin, N-nitrosodiethylamine and phenobarbital were procured 
from sigma chemical company, St Louis, MO, USA. Embelin was 
kindly isolated and given as a gift by Prof. Narayanan, department 
of pharmaceutics, Madras medical college, Chennai, India. 
 
 
Animals 
 
Adult male albino rats of wistar strain weighing between 120 – 140 
g obtained from the authentic animal sources of the university were 
used for the study. They were acclimatized to animal house condi-
tions and were fed on commercial pelleted rat chow (Hindustan 
Lever Limited, Bangalore, India) and water ad libitum (This study 
was conducted following the ethical guidelines for maintaining 
animals). 
 
 
Experimental protocols 
 
The animals were divided into 6 groups of 6 rats each according to 
the following experimental regimen. Group 1 comprised normal 
control rats. Group 2 was rats given a single intraperitoneal in-
jection of DENA (200 mg/kg). After a brief recovery period of 1 
week the rats were given PB (0.05% in drinking water). The admini-
stration of phenobarbital was continued for another 13 weeks. 
Group 3 was rats given curcumin per se (100 mg/kg body weight 
suspended in tween-20 for a period of 14 weeks). Group 4 was 
rats, which were given embelin per se (50 mg/kg body weight 
suspended in tween-80 for 14 weeks). Group 5 was rats, which 
were given curcumin 1 week prior to the injection of DENA. The oral 
administration was then continued throughout the experimental 
period (14 weeks) along with the administration of phenobarbital. 
Group 6 were rats, which were given embelin one week prior to the 
injection of DENA. As in group 5, group 6 rats were orally admini-
stered with embelin throughout the experimental period (14 weeks). 
After the experimental period, the animals were sacrificed by 
cervical decapitation under ether anesthesia following animal ethics 
guidelines. Blood and serum obtained from the animals were used 
for the estimation of glucose (Sasaki et al., 1972), urea (Natelson et 
al., 1951), creatinine (Broad and Sirota, 1948), cholesterol (Parekh 
and Jung, 1970), triglycerides (Foster and Dunn, 1973), free fatty 
acids (FFA) (Hron and Menahan, 1981), very-low-density lipo-
proteins (VLDL), low-density lipoproteins (LDL), and high-density 
lipoproteins (HDL). 
 
 
Statistical analysis  
 
Statistical analysis was carried out by student’s-t-test. Values are 
expressed as mean + SD and “p” values were determined. Inter 
group comparisons were made between group 2, group 3 and 
group 4 Vs group 1; group 5, group 6 Vs group 2. 
 
 
RESULTS 
 
Table 1 indicates the levels of urea, creatinine and glu-
cose in normal and experimental groups of rats. Results 
indicate that the levels of urea showed a decrease (P < 
0.05), glucose showed an increase (P < 0.001) and there 
was no significant change in the creatinine levels in the 
group 2 cancer induced rats; group 3 and group 4 rats 
given curcumin and embelin per se respectively did not 
show any alteration in the levels of urea, creatinine and 
glucose as compared to control. Group 5 and group 6 
rats showed significant increase in the urea (P < 0.05) 
and decrease in glucose [group 5 (P < 0.001), group 6 (P 
< 0.01)] and no significant changes in the creatinine 
levels as compared to the cancer -induced rats.  
Table  2  indicates  that  levels  of  cholesterol,  triglyce- 
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Table 2. Levels of cholesterol, triglycerides, free fatty acids, LDL, HDL and VLDL in the normal and experimental groups 
of rats. 
 
Group Cholesterol Triglycerides FFA LDL HDL VLDL 
1 92.30 ± 6.81 52.8 ±4.09 27.31 ± 1.98 49.82 ± 3.97 31.92 ± 2.26 10.56 ± 1.09 
2 140.25 ± 9.57*** 189.25 ± 9.62*** 48.85 ± 3.26*** 81.64 ± 7.63*** 20.76 ± 1.87*** 37.85 ± 2.94*** 
3 94.89 ± 8.34NS 50.92 ± 4.35 NS 25.81 ± 2.03 NS 52.74 ± 4.39NS 31.97 ± 3.01 NS 10.184 ± 1.12NS 
4 90.66 ± 7.34NS 52.16 ± 3.28 NS 26.07 ± 1.98 NS 51.18 ± 5.02 NS 29.05 ± 2.65 NS 10.432 ± 0.97NS 
5 116.53 ± 10.62*** 106.85 ± 9.12*** 36.47 ± 2.77*** 70.18 ± 7.09* 24.98 ± 2.05** 21.37 ± 2.05*** 
6 118.29 ± 12.05*** 116.05 ± 9.33*** 38.19 ± 3.12*** 69.17 ± 7.05** 25.91 ± 2.47** 23.21 ± 1.93*** 
 
Unis: mg/dl. 
Values are expressed as mean + SD. (For 6 animals in each group).  
Students`t’ test - Comparisons are made between group 2 and group 1; group 3 and group1; group 4 and group1; group 5 and 
group 2; group 6 and group 2. 
*** P < 0.001; ** P < 0.01; * P < 0.05; NS - non significant. 
 
 
 
rides, free fatty acids, LDL, HDL and VLDL in the normal 
and experimental groups of rats. Group 2 cancer-induced 
rats showed hypercholesterolemia (P < 0.001), hypertri-
glyceridemia (P < 0.001), increase in the free fatty acid, 
LDL, VLDL and decrease in HDL as compared to the 
control rats. Group 3 and group 4 rats showed no signi-
ficant change in the above mentioned parameters as 
compared to control. The group 5 and group 6 rats show-
ed a considerably low levels of cholesterol, triglycerides, 
free fatty acids, LDL, VLDL and an appreciable increase 
in the HDL cholesterol as compared to the group 2 rats 
given DENA/PB. 
 
 
DISCUSSION 
 
The essential nature of any cancer in humans or in ani-
mals continues to challenge many scientists and practi-
tioners interested in the biology, prevention and therapy 
of this disease. N-nitrosodiethylamine is a powerful heap-
tocarcinogen known to induce cancer in experimental 
animals (Pereira et al., 1984). Phenobarbital acts as a 
tumor promoter when administered subsequent to an 
initiating carcinogen like N-nitrosodiethylamine. Combina-
tion of DENA/PB has been used as a model to screen for 
the antiproliferative effects of several pharmaceutical 
agents in experimental animals (Watanabe et al., 2001).  
The results of the present study provide substantial 
support for the protective and hypolipidemic effects of 
curcumin and embelin during DENA/PB-induced hepato-
carcinogenesis in rats. The decrease in urea levels 
observed in the group 2 rats could be attributed to the 
declining function of the liver which is the primary site for 
the synthesis of urea. Several studies earlier, report a de-
crease in urea levels during liver dysfunction including 
hepatitis and cirrhosis (Kikuchi et al., 1994; Anandan et 
al., 1999). During hepatic injury blood urea level declines 
significantly due to the failure of the liver to convert amino 
acids and ammonia to urea (Schmike, 1962). Hypergly-
cemia is usually associated with insulin resistance during 
gastrointestinal cancers and in the present study also it is 
possible that the observed increase in glucose levels 
could be due to the toxicity caused to the pancreatic islet 
cells and due to the alteration in carbohydrate meta-
bolism by the administration of DENA/PB (Kuklin et al., 
2004). The carcinogen exposed rats treated with cur-
cumin and embelin respectively showed an amelioration 
of the altered biochemical parameters towards normalcy 
giving an indication of the protective effect of these 2 
compounds during DENA/PB-induced hepatocarcino-
genesis in rats.  
A number of agents that produce liver injury also cause 
the accumulation of abnormal amounts of fat, predomi-
nantly triglycerides, in the parenchymal cells. In general, 
triglyceride accumulation can be thought of as resulting 
from an imbalance between the rate of synthesis and the 
rate of release of triglycerides by the parenchymal cells 
into the systemic circulation (Plaa and Wewitt 1989). Non 
esterified fatty acids removed from the circulation or 
synthesized endogenously are processed thorough 2 
major pathways in liver: (a) Mitochondrial beta oxidation 
for production of metabolic energy and (b) incorporation 
into complex lipids, especially triglycerides, phosphor-
lipids, cholesterol esters and glycolipids (Dianzani and 
Slatter, 1978). 
Once synthesized, the complex lipids may be conti-
nuously secreted from the liver into the blood. The latter 
pathway appears to be of greater interest in the trigly-
ceride accumulation observed in the fatty liver caused by 
the administration of the DENA/PB in our study. Several 
earlier studies report increased accumulation of serum 
cholesterol, triglycerides and free fatty acids during 
DENA/PB induced hepatocarcinogenesis in rats (Jiang et 
al., 2006). In accordance with these reports we also ob-
served a significant increase in serum cholesterol trigly-
cerides and free fatty acids during DENA/PB-induced 
hepatic cancer. An appreciable decrease in the aforesaid 
parameters observed in the group 5 and group 6 rats 
given DENA/PB + CUR and DENA/PB + EMB respec-
tively gives an indication about the hypolipidaemic effects  
  
 
 
of these 2 compounds. This might be indirectly related to 
the antiperoxidative and inhibitory effects on lipid peroxi-
dation chain reaction, of the 2 compounds during DENA/ 
PB-induced hepatocarcinogenesis in rats (Sreepriya and 
Bali, 2006).  
The decreased levels of HDL and a significant increase 
in the levels of LDL and VLDL observed in the group 2 
cancer-induced rats indicate clearly the hyperlipidaemic 
conditions caused by exposure to carcinogens. On the 
contrary, a substantial decrease in the levels of LDL and 
VLDL coupled with a considerable increase in HDL indi-
cate the beneficial effects of administration of curcumin 
and embelin during DENA/PB-induced hepatocarcino-
genesis in rats. The clear mechanism of action for the 
observed hypolipidaemic effects is not well understood at 
this stage of study. It is believed that it could be due to a 
cumulative protective effect contributed by its antioxidant 
and antiperoxidative effects coupled with an ability to 
correct the abnormalities in lipid and lipoprotein meta-
bolism through an increase in the activities of few lipid 
metabolizing enzymes Viz lecithin cholesterol acyl trans-
ferase, lipoprotein lipase and hepatic triglyceride lipase. 
Further studies are underway in our laboratory to under-
stand the actual mechanism of the drugs contributing to 
its hypolipidaemic effect.   
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